Omada Health vs Winona
A detailed head-to-head comparison of Omada Health and Winona — pricing, peptides, consultation models, and patient reviews.
At a Glance
RatingNo reviews
Starting PriceN/A
Peptides2
ConsultationHybrid
Lab TestingNo
Shipping3-5 business days
Pros
- Employer and payer-sponsored access means $0 platform cost for many patients
- Behavior change programming is more structured and intensive than most GLP-1 telehealth platforms
- Long-term chronic disease management focus supports patients beyond the initial prescription phase
- Dedicated health coach provides ongoing accountability and behavior support throughout treatment
- Track record dating to 2011 with significant evidence base on diabetes prevention and weight management outcomes
- Integrated management of hypertension, diabetes, and weight within one platform for patients with multiple conditions
Cons
- Not accessible to patients without employer or health plan coverage unless they pursue direct enrollment (which lacks transparent pricing)
- Not designed for fast prescription access
- GLP-1 prescribing is one component of a larger program; patients who only want medication management may find the program structure more than they need
- Geographic expansion of direct access and specific health plan participation is not clearly documented publicly
- The coaching layer is strong, but clinical depth for complex cases is not equivalent to obesity medicine specialists
- Compounded GLP-1 availability subject to same regulatory pressures as all other telehealth platforms
RatingNo reviews
Starting PriceN/A
Peptides2
ConsultationHybrid
Lab TestingNo
Shipping3-5 business days
Pros
- Female-only clinician panel is a meaningful differentiator for the 40+ demographic
- Integrated HRT + GLP-1 co-management addresses the actual biology of perimenopause-related weight gain
- Detailed hormonal intake creates more clinical context than standard weight-loss telehealth intake forms
- Asynchronous model is accessible and does not require scheduling around rigid appointment slots
- Platform designed specifically for this population
Cons
- Not appropriate for women outside the perimenopausal/menopausal demographic seeking GLP-1 treatment
- Cash-pay model with limited insurance integration means costs are fully out-of-pocket for most patients
- Compounded semaglutide availability is uncertain post-FDA enforcement; patients should confirm formulation options at time of consultation
- Async-first model may be insufficient for patients with complex or rapidly changing metabolic presentations
- Less brand recognition than larger platforms, which may make some patients hesitant despite clinical appropriateness
Pros & Cons
Peptide Pricing Comparison
| Peptide | Omada Health | Winona |
|---|---|---|
| Semaglutide | Price unavailable | Price unavailable |
| Tirzepatide | Price unavailable | Price unavailable |
Frequently Asked Questions
Is Omada Health or Winona better?
Omada Health offers 2 peptides and hybrid consultations. Winona offers 2 peptides and hybrid consultations. The best choice depends on which peptides you need, your budget, and preferred consultation model.
Which is cheaper, Omada Health or Winona?
See the pricing table above for a detailed comparison.